Trial Profile
Efficacy and Safety of Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies Fail to Eltrombopag or Herombopag Treatment: a Single-center, Prospective, One-arm Clinical Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2023
Price :
$35
*
At a glance
- Drugs Avatrombopag (Primary)
- Indications Idiopathic thrombocytopenic purpura; Rheumatoid arthritis; Sjogren's syndrome; Systemic lupus erythematosus
- Focus Therapeutic Use
- 13 Aug 2021 New trial record